09/02/2026 - General information
The use of a standardized protocol significantly reduces headache after lumbar puncture, one of the most common side effects of this procedure, based on the analysis of more than 1,100 punctures. Improving the tolerability of lumbar puncture is key to advancing research in the preclinical stages of Alzheimer's disease and has been made possible thanks to the commitment of volunteers from the ALFA cohort. The study, published in Nature Scientific Reports, involved 724 cognitively healthy adults from the longitudinal ALFA cohort at the BBRC, with the support of the "la Caixa" Foundation.
02/02/2026 - General information
The Machine of Forgetting is a guide to understanding how memory works and how it defines who we are. Through eleven questions, it explores a wide range of issues, from how we store memories to what makes us human, including the possibility that androids might have feelings. Published by Editorial Ariel, the new book by Dr. Rodrigo Quian Quiroga, neuroscientist at the Hospital del Mar Research Institute and ICREA professor, opens the door to the latest advances in neuroscience and artificial intelligence research, while also establishing parallels with art, philosophy, and football.
13/01/2026 - General information
The journal Nature Mental Health has published a landmark scientific article on the prevention of depression and suicidal behaviour through an evidence-based programme designed to reduce depression and suicidal behaviour: the 4-Level Community Intervention, developed by the European Alliance Against Depression (EAAD). The EAAD approach offers a sustainable model of community-based mental health care that can be effectively adapted to a wide range of contexts, including current and future public health emergencies.
29/12/2025 - General information
A clinical trial led by a team from the Hospital del Mar Research Institute, in collaboration with Hospital de la Santa Creu i Sant Pau, has received nearly €1.3 million in funding from Spain's Carlos III Health Institute (ISCIII), under the 2025 call of the Strategic Action in Health-Strategic Lines of Health Research. It is one of the 14 clinical trials selected. The trial is led by Dr. Ana Aldea, coordinator of the HMRIB Clinical Research Unit and Head of the Clinical Pharmacology Section at Hospital del Mar, and Dr. Rafael de la Torre, coordinator of the Integrated Pharmacology and Systems Neuroscience Research Group at the Hospital del Mar Research Institute.
10/06/2025 - General information
The Spanish Society of Neurology has awarded the scientific career of the coordinator of the Multiple Sclerosis Unit at Hospital del Mar and the coordinator of the Neuroimmunology Research Group at its research institute. Dr. José Enrique Martínez received the 'Premio SEN Esclerosis Múltiple' on June 4th, during the Institutional Ceremony of the Spanish Society of Neurology, recognizing his scientific work in this field. These awards represent the SEN's recognition of individuals or entities that have contributed to the development of neurology.
Més informació "SEN Multiple Sclerosis Award for Dr. José Enrique Martínez"
25/03/2025 - General information
A new study led by researchers from the Hospital del Mar Research Institute and the Barcelonaβeta Brain Research Center (BBRC), the research centre of the Pasqual Maragall Foundation, has made significant strides in the search for effective blood-based biomarkers for Alzheimer's disease early detection. The research, published in the journal Alzheimer's & Dementia, provides a comprehensive comparison of various plasma biomarkers and their accuracy in detecting Alzheimer's disease in a memory clinic setting.
17/03/2025 - General information
The BAPP, a joint center between the Hospital del Mar Research Institute and Pompeu Fabra University, will maintain this quality seal from the Government of Catalonia until 2028. This recognition highlights its scientific and technical excellence, as well as its capacity for knowledge and technology transfer to the industry. The BioAnalysis, Proteomics and Pharmacology Center (BAPP), part of the Hospital del Mar Research Institute and Pompeu Fabra University, has renewed its TECNIO accreditation, awarded by the Government of Catalonia through ACCIÓ. This accreditation, valid until 2028, identifies and gives visibility to highly capable scientific and technical centers, recognized as developers of cutting-edge technologies and leaders in technology and knowledge transfer to the industry.
Més informació "The Hospital del Mar Research Institute renews the TECNIO accreditation"
07/02/25 - General information
The Hospital del Mar Research Institute and the company Bionure have signed an agreement to establish a strategic collaboration between the two institutions. The objective is the development of new RNA-based therapies for the treatment of neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS). The research center will be responsible for conducting proof-of-concept studies for potential medications, both in patient cells and in animal models, which is a necessary step before starting clinical trials in humans. RNA therapies for these types of pathologies are a promising tool not only to slow disease progression but also to potentially repair neuronal damage in neurodegenerative diseases with a genetic component.
22/11/2024 - General information
This project will study the short- and long-term impact of steroid sulfation, which is involved in various biological processes, during pregnancy and its influence on maternal mental health and the mother-child bond. The project, "Short- and Long-term Effects of Steroid Sulfation During Pregnancy on Brain Plasticity, Maternal Well-being, and the Mother-Child Bond", led by Dr. Òscar Vilarroya, coordinator of the Neuroimaging of Mental Disorders Research Group at the Hospital del Mar Research Institute, will receive funding from La Marató de TV3 and Catalunya Ràdio. It is one of 26 projects related to sexual and reproductive health selected by the Board of Trustees of La Marató Foundation upon the recommendation of the Advisory Commission. Over 100 proposals were submitted in this edition.
20/11/2024 - General information
The project has received one of the recognitions in the Responsible Research and Innovation in Health awards. The award highlights the added value of the project for incorporating public participation in its design. The PENSA study aims to contribute to the research of effective treatments to prevent or delay dementia.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
